Global Medical REIT (GMRE) Earning Somewhat Favorable Media Coverage, Analysis Finds
Press coverage about Global Medical REIT (NYSE:GMRE) has trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Global Medical REIT earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.6765887577616 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the headlines that may have impacted Accern’s scoring:
- Global Medical REIT (GMRE) versus Gramercy Property Trust (GPT) Financial Contrast (americanbankingnews.com)
- Global Medical REIT (GMRE) PT Set at $11.00 by B. Riley (americanbankingnews.com)
- FY2018 Earnings Forecast for Global Medical REIT Inc Issued By DA Davidson (GMRE) (americanbankingnews.com)
- Global Medical REIT (GMRE) Q2 FFO Meet Estimates (finance.yahoo.com)
- Boenning Scattergood Reiterates Hold Rating for Global Medical REIT (GMRE) (americanbankingnews.com)
GMRE has been the subject of several analyst reports. Zacks Investment Research upgraded shares of Global Medical REIT from a “hold” rating to a “strong-buy” rating and set a $9.75 target price for the company in a research note on Wednesday, May 9th. B. Riley decreased their target price on shares of Global Medical REIT from $10.50 to $10.00 and set a “buy” rating for the company in a research note on Thursday, May 10th. Boenning Scattergood restated a “neutral” rating on shares of Global Medical REIT in a research note on Friday, June 29th. Finally, TheStreet upgraded shares of Global Medical REIT from a “d” rating to a “c-” rating in a research note on Friday, June 29th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $10.30.
Global Medical REIT (NYSE:GMRE) last announced its earnings results on Tuesday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.01). The firm had revenue of $13.25 million during the quarter, compared to analysts’ expectations of $12.86 million. Global Medical REIT had a net margin of 8.00% and a return on equity of 1.91%. equities research analysts predict that Global Medical REIT will post 0.83 EPS for the current year.
About Global Medical REIT
Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company's management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers.
See Also: Diversification in Your Portfolio
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.